FDA Drops Placebo-Controlled Trial Requirement for NEW mRNA Vaccines

"The FDA reversed course and accepted an amended application with the promise that Moderna would conduct an additional study in older adults once the (mRNA flu) vaccine is approved.” - REUTERS

May 28, 2026

∙ Paid

May 28, 2026: REUTERS reported that the FDA is currently reviewing Moderna’s mRNA flu vaccine and that the FDA will be holding a meeting of outside experts next month (June 2026) to review Moderna’s biological license application (BLA).

This Kingston Report is public. Feel free to share!

Background

May 21, 2025: The FDA announced that the agency would be…

FDA Drops Placebo-Controlled Trial Requirement for NEW mRNA Vaccines

"The FDA reversed course and accepted an amended application with the promise that Moderna would conduct an additional study in ​older adults once the (mRNA flu) vaccine is approved.” - REUTERS

Background

This post is for paid subscribers

"The FDA reversed course and accepted an amended application with the promise that Moderna would conduct an additional study in older adults once the (mRNA flu) vaccine is approved.” - REUTERS